Alfonso Quintas Cardama - Nov 17, 2022 Form 4 Insider Report for TCR2 THERAPEUTICS INC. (TCRR)

Role
Chief Medical Officer
Signature
/s/ Margaret Siegel as Attorney-in-Fact
Stock symbol
TCRR
Transactions as of
Nov 17, 2022
Transactions value $
$0
Form type
4
Date filed
11/18/2022, 03:38 PM
Previous filing
Dec 10, 2021
Next filing
Dec 5, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding TCRR Common Stock 46.9K Nov 17, 2022 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction TCRR Stock Option (right to buy) Disposed to Issuer $0 -5.8K -100% $0.00* 0 Nov 17, 2022 Common Stock 5.8K $16.11 Direct F1, F2
transaction TCRR Restricted Stock Unit (right to buy) Award $0 +1.93K $0.00 1.93K Nov 17, 2022 Common Stock 1.93K Direct F2, F3, F4
transaction TCRR Stock Option (right to buy) Disposed to Issuer $0 -206K -100% $0.00* 0 Nov 17, 2022 Common Stock 206K $16.11 Direct F1, F5
transaction TCRR Restricted Stock Unit (right to buy) Award $0 +68.5K $0.00 68.5K Nov 17, 2022 Common Stock 68.5K Direct F3, F4, F5
transaction TCRR Stock Option (right to buy) Disposed to Issuer $0 -3.31K -100% $0.00* 0 Nov 17, 2022 Common Stock 3.31K $16.10 Direct F6, F7
transaction TCRR Restricted Stock Unit (right to buy) Award $0 +1.1K $0.00 1.1K Nov 17, 2022 Common Stock 1.1K Direct F3, F7, F8
transaction TCRR Stock Option (right to buy) Disposed to Issuer $0 -68.8K -100% $0.00* 0 Nov 17, 2022 Common Stock 68.8K $16.10 Direct F6, F9
transaction TCRR Restricted Stock Unit (right to buy) Award $0 +22.9K $0.00 22.9K Nov 17, 2022 Common Stock 22.9K Direct F3, F8, F9
transaction TCRR Stock Option (right to buy) Disposed to Issuer $0 -4.49K -100% $0.00* 0 Nov 17, 2022 Common Stock 4.49K $31.83 Direct F10, F11
transaction TCRR Restricted Stock Unit (right to buy) Award $0 +816 $0.00 816 Nov 17, 2022 Common Stock 816 Direct F3, F11, F12
transaction TCRR Stock Option (right to buy) Disposed to Issuer $0 -96.5K -100% $0.00* 0 Nov 17, 2022 Common Stock 96.5K $31.83 Direct F10, F13
transaction TCRR Restricted Stock Unit (right to buy) Award $0 +17.5K $0.00 17.5K Nov 17, 2022 Common Stock 17.5K Direct F3, F12, F13
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This cancelled option vested 25% on January 1, 2020 and the remaining 75% vests in 36 substantially equal monthly installments thereafter.
F2 On November 17, 2022, the issuer canceled, pursuant to the issuer's offer to exchange eligible options for new restricted stock units program, a stock option granted to the reporting person on April 11, 2019. In exchange for such stock option, the reporting person received restricted stock units in the amount of 1,933.
F3 Each restricted stock unit represents a right to receive one share of the issuer's common stock at the time of vesting for no consideration.
F4 The restricted stock units will vest 98% on December 1, 2022, and 2% on December 1, 2023.
F5 On November 17, 2022, the issuer canceled, pursuant to the issuer's offer to exchange eligible options for new restricted stock units program, a stock option granted to the reporting person on April 11, 2019. In exchange for such stock option, the reporting person received restricted stock units in the amount of 68,501.
F6 This cancelled option vested 25% on January 1, 2021 and the remaining 75% vests in 36 substantially equal monthly installments thereafter.
F7 On November 17, 2022, the issuer canceled, pursuant to the issuer's offer to exchange eligible options for new restricted stock units program, a stock option granted to the reporting person on December 19, 2019. In exchange for such stock option, the reporting person received restricted stock units in the amount of 1,103.
F8 73% of these RSUs will vest on December 1, 2022, 25% will vest on December 1, 2023 and the remaining 2% will vest on December 1, 2024.
F9 On November 17, 2022, the issuer cancelled, pursuant to the issuer's offer to exchange eligible options for new restricted stock units program, a stock option granted to the reporting person on December 19, 2019. In exchange for such stock option, the reporting person received restricted stock units in the amount of 22,931.
F10 This cancelled option vested 25% on January 1, 2022 and the remaining 75% vests in 36 substantially equal monthly installments thereafter.
F11 On November 17, 2022, the issuer cancelled, pursuant to the issuer's offer to exchange eligible options for new restricted stock units program, a stock option granted to the reporting person on December 10, 2020. In exchange for such stock option, the reporting person received restricted stock units in the amount of 816.
F12 48% of these RSUs will vest on December 1, 2022, 25% will vest on December 1, 2023, another 25% will vest on December 1, 2024 and the remaining 2% will vest on December 1, 2025.
F13 On November 17, 2022, the issuer cancelled, pursuant to the issuer's offer to exchange eligible options for new restricted stock units program, a stock option granted to the reporting person on December 10, 2020. In exchange for such stock option, the reporting person received restricted stock units in the amount of 17,548.